Senator Amy Klobuchar: “If we allow the government to negotiate directly with pharmaceutical companies, it’s going to mean lower drug prices and billions in savings. We can fix this in this reconciliation bill. This is our moment.” #LowerDrugPricesNOW
We're LIVE with Senator Amy Klobuchar for a virtual rally to demonstrate the growing momentum for giving #Medicare the power to negotiate for #LowerDrugPrices. Join us:
If lawmakers need another reason to close the Medicaid coverage gap, look no further than today’s Census data. As it stands, millions of people in states like Texas, Florida, and Georgia are blocked from accessing affordable coverage because of Republican lawmakers’ refusal to do the right thing. Medicaid expansion improves care, strengthens economies, and saves lives. nnClosing the coverage gap is the single most important thing Congress can do to address the inequities laid bare by the pandemic. The millions of people in the coverage gap cannot wait. The time to act is now.
NEW DATA: As Congress works on a budget plan that includes giving #Medicare the power to negotiate #LowerDrugPrices, our new project with Data for Progress and Patients for Affordable Drugs shows the overwhelming, bipartisan support for this reform in every district. nnIn every district and every state, constituents and lawmakers can now find out the support for reform, opinions about the pharmaceutical companies, concerns about congressional action, and belief in pharma’s top arguments.
TOMORROW: Senator Amy Klobuchar will join health care storytellers and advocates from across the country for a virtual rally to highlight the growing momentum for giving #Medicare the power to negotiate for #LowerDrugPrices. RSVP today: https://www.facebook.com/events/575694773863886/
"Closing the Medicaid coverage gap means an estimated 2.2 million people—60% of whom are people of color, and 324,000 of whom are disabled—would get access to quality insurance at little or no cost."
Medication and health care are expensive. But it doesn’t have to be.
We have a once-in-a-generation opportunity to finally bring down drug prices for American families. The time to act is now.